3741 - 3750 of 7916 Results
Title
Year
-
OPENTitle: What's happening in Neurology ® Clinical PracticeJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 95Issue #: 16Start Page: 727End Page: 727Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000010792Best OA location URL: https://n.neurology.org/content/neurology/95/16/727.full.pdfCitation Count: 0
- Long genes are more frequently affected by somatic mutations and show reduced expression in Alzheimer's disease: Implications for disease etiology2020OPENTitle: Long genes are more frequently affected by somatic mutations and show reduced expression in Alzheimer's disease: Implications for disease etiologyJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 17Issue #: 3Start Page: 489End Page: 499Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/alz.12211Best OA location URL: https://doi.org/10.1002/alz.12211Citation Count: 22
-
OPENTitle: The Human Coronavirus Receptor ANPEP (CD13) Is Overexpressed in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 12Start Page: 2134End Page: 2136Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28354Best OA location URL: https://eprints.ncl.ac.uk/file_store/production/271876/552911A9-469D-41EA-AA8A-F7B7D5C04187.pdfCitation Count: 4
- A 12-month, dose-level blinded safety and efficacy study of levodopa inhalation powder (CVT-301, Inbrija) in patients with Parkinson's disease2020OPENTitle: A 12-month, dose-level blinded safety and efficacy study of levodopa inhalation powder (CVT-301, Inbrija) in patients with Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 81Issue #:Start Page: 144End Page: 150Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.10.029Best OA location URL: http://www.prd-journal.com/article/S1353802020308221/pdfCitation Count: 16
- Epigenome-wide association study of Alzheimer’s disease replicates 22 differentially methylated positions and 30 differentially methylated regions2020OPENTitle: Epigenome-wide association study of Alzheimer’s disease replicates 22 differentially methylated positions and 30 differentially methylated regionsJournal Name: Clinical EpigeneticsPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13148-020-00944-zBest OA location URL: https://clinicalepigeneticsjournal.biomedcentral.com/track/pdf/10.1186/s13148-020-00944-zCitation Count: 58
-
OPENTitle: Lower Urinary Tract and Gastrointestinal Dysfunction Are Common in Early Parkinson’s DiseaseJournal Name: Parkinson's DiseasePublisher: Hindawi LimitedVol: 2020Issue #:Start Page: 1End Page: 8Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2020/1694547Best OA location URL: https://downloads.hindawi.com/journals/pd/2020/1694547.pdfCitation Count: 12
- Altered Functional Network Associated With Cognitive Performance in Early Parkinson Disease Measured by Eigenvector Centrality Mapping2020OPENTitle: Altered Functional Network Associated With Cognitive Performance in Early Parkinson Disease Measured by Eigenvector Centrality MappingJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2020.554660Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2020.554660/pdfCitation Count: 6
-
RESTRICTEDTitle: Inflammatory bowel disease and Parkinson’s disease: common pathophysiological linksJournal Name: GutPublisher: BMJVol:Issue #:Start Page: gutjnlEnd Page: 322429Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1136/gutjnl-2020-322429Best OA location URL: https://lirias.kuleuven.be/bitstream/123456789/663875/2/gutjnl-2020-322429_main_18_Aug_clean.pdfCitation Count: 93
- Precision medicine in Parkinson’s disease patients with LRRK2 and GBA risk variants – Let’s get even more personal2020RESTRICTEDTitle: Precision medicine in Parkinson’s disease patients with LRRK2 and GBA risk variants – Let’s get even more personalJournal Name: Translational NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40035-020-00218-xBest OA location URL: https://translationalneurodegeneration.biomedcentral.com/track/pdf/10.1186/s40035-020-00218-xCitation Count: 29
- Gait Progression Over 6 Years in Parkinson’s Disease: Effects of Age, Medication, and Pathology2020OPENTitle: Gait Progression Over 6 Years in Parkinson’s Disease: Effects of Age, Medication, and PathologyJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2020.577435Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2020.577435/pdfCitation Count: 50